Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands

OBJECTIVES: Intratypic molecular variants of human papillomavirus (HPV) type-16 and -18 exist. In the Netherlands, a bivalent vaccine, composed of recombinant L1 proteins from HPV-16 and -18, is used to prevent cervical cancer since 2009. Long-term vaccination could lead to changes in HPV-16 and -18...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:PLoS One
Glavni autori: King, Audrey J., Sonsma, Jan A., Vriend, Henrike J., van der Sande, Marianne A. B., Feltkamp, Mariet C., Boot, Hein J., Koopmans, Marion P. G.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2016
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829201/
https://ncbi.nlm.nih.gov/pubmed/27070907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0152782
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items